[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343909-105":59,"doc-detail-343909-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","glycosyltransferase-b4galnt1-promotes-immunosuppression-in-hepatocellular-carcinoma-via-the-hes4-spp1-tamth2-axis-abstract","Glycosyltransferase B4GALNT1 promotes immunosuppression in hepatocellular carcinoma via the HES4-SPP1-TAM/Th2 axis - Abstract","","B4GALNT1 is a key glycosyltransferase involved in ganglioside biology, with aberrant expression reported across multiple cancers. Its role in tumor immunity and progression in hepatocellular carcinoma remains unclear. This study shows that B4GALNT1 is upregulated in HCC tissues and cells, serving as an independent prognostic factor and improving TNM-based prediction. Mechanistically, B4GALNT1 activates HES4 via p38/JNK-dependent phosphorylation, driving SPP1 production, reshaping tumor-associated macrophages and Th2 cells, and producing an immunosuppressive microenvironment. Silencing B4GALNT1 enhances PD-1 targeting antitumor efficacy in mouse models.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/glycosyltransferase-b4galnt1-promotes-immunosuppression-in-hepatocellular-carcinoma-via-the-hes4-spp1-tamth2-axis-abstract/343909/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/glycosyltransferase-b4galnt1-promotes-immunosuppression-in-hepatocellular-carcinoma-via-the-hes4-spp1-tamth2-axis-abstract/343909.png","ImageObject",300,407,{"name":92,"@type":93},"Quinn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main focus of the study on B4GALNT1 in hepatocellular carcinoma?","Question",{"text":112,"@type":113},"The study investigates how B4GALNT1 regulates tumor progression and the tumor immune microenvironment in hepatocellular carcinoma, and assesses targeting B4GALNT1 as an auxiliary strategy for immunotherapy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does B4GALNT1 influence immunosuppression according to the proposed mechanism?",{"text":117,"@type":113},"B4GALNT1 increases phosphorylation and transcriptional activity of HES4 through p38/JNK signaling, which elevates synthesis and secretion of SPP1 and reshapes tumor-associated macrophages and Th2 cells to form an immunosuppressive microenvironment.",{"name":119,"@type":110,"acceptedAnswer":120},"What evidence supports the prognostic value of B4GALNT1 in HCC?",{"text":121,"@type":113},"B4GALNT1 is verified as aberrantly upregulated in HCC tumor tissues and cells, and it is reported to act as an independent prognostic factor while improving prediction performance over traditional TNM staging.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},343909,1790211312,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962075114765,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Wang et al. Molecular Biomedicine (2024) 5:65 [https://doi.org/10.1186/s43556-024-00231-w](https://doi.org/10.1186/s43556-024-00231-w)  \nMolecular Biomedicine  \n RESEARCH Open Access  \nGlycosyltransferase B4GALNT1 promotes immunosuppression in hepatocellular  \ncarcinoma via the HES4-SPP1-TAM/Th2 axis  \nZhifeng Wang1,3,4†, Jiaxin Liu1,4†, Xiaoming Wang3†, Qingyun Wu1,4, Qiao Peng5, Tianxiao Yang1, Xuehui Sun1,4, Xiaofeng Wang1,4, Yilin Wang2* and Weicheng Wu1,3,4*  \nAbstract  \nβ-1,4-N-acetylgalactosaminyltransferase I (B4GALNT1) is a key glycosyltransferase for gangliosides. Its aberrant expression has been observed in various cancers, and its potential roles in tumor immunity were suggested recently. However, how B4GALNT1 regulate tumor progression and tumor immunity remains largely unknown. In this study, we aimed to investigate the roles of B4GALNT1 in hepatocellular carcinoma (HCC), particularly in reshaping the tumor immune microenvironment, and evaluate the potential beneficial effects of targeting B4GALNT1 in immunotherapy. Our data verified the aberrant upregulation of B4GALNT1 in HCC tumor tissues and tumor cells, which could be utilized as an independent prognostic factor and improve the predicting performance of traditional tumor node metastasis (TNM) system. We also demonstrated that B4GALNT1 increased the phosphorylation of Hes Family BHLH Transcription Factor 4 (HES4) via p38 mitogen-activated protein kinase (p38)/ c-Jun N-terminal kinase (JNK) signaling in tumor cells, thus increasing the transcriptional activity of HES4, which upregulated the synthesis and secretion of secreted phosphoprotein 1 (SPP1), modulated the composition of tumor-associated macrophages (TAMs) and T helper type 2 (Th2) cells, and eventually reshaped the immunosuppressive microenvironment. In addition, silencing B4GALNT1 was proved to enhance the tumor-killing efficiency of the programmed cell death protein 1 (PD-1)-targeting strategy in mouse model. In conclusion, this study evaluated B4GALNT1 as a prognostic predictor for HCC patients and revealed the mechanism of B4GALNT1 in microenvironmental remodeling, which extends the understanding of HCC progression and provides a novel auxiliary strategy for HCC immunotherapy.  \nKeywords Hepatocellular carcinoma, B4GALNT1, Prognosis, Immunosuppression  \n†Zhifeng Wang, Jiaxin Liu and Xiaoming Wang share co-first authorship.  \n*Correspondence:  \nYilin Wang[linglingwangyi@126.com](linglingwangyi@126.com)[ ](linglingwangyi@126.com)Weicheng Wu [wuweicheng@fudan.edu.cn](wuweicheng@fudan.edu.cn)  \n1 Human Phenome Institute, State Key Laboratory of Genetic Engineering and MOE Key Laboratory of Contemporary Anthropology, School of Life Sciences, Fudan University, Shanghai, China  \n2 Department of Hepatic Surgery, Department of Oncology, Shanghai Medical College, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China  \n3 Department of Hepatobiliary Surgery, The First Affiliated Hospital ofWannan Medical College, Wuhu, China  \n4 Fudan University-the People’s Hospital of Rugao Joint Research Institute of Longevity and Ageing, Rugao, Jiangsu, China  \n5 Shanghai Tenth People’s Hospital, School of Medicine, Tongji University Cancer Center, Tongji University, Shanghai, China  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will ne","cbCaihzrfgFwDrtb","https://ap.wps.com/l/cbCaihzrfgFwDrtb","pdf",16976899,21,"English","# Introduction\n## Background on hepatocellular carcinoma and immunotherapy\n## Immune checkpoint inhibition and resistance in HCC","[{\"question\":\"What is the main focus of the study on B4GALNT1 in hepatocellular carcinoma?\",\"answer\":\"The study investigates how B4GALNT1 regulates tumor progression and the tumor immune microenvironment in hepatocellular carcinoma, and assesses targeting B4GALNT1 as an auxiliary strategy for immunotherapy.\"},{\"question\":\"How does B4GALNT1 influence immunosuppression according to the proposed mechanism?\",\"answer\":\"B4GALNT1 increases phosphorylation and transcriptional activity of HES4 through p38/JNK signaling, which elevates synthesis and secretion of SPP1 and reshapes tumor-associated macrophages and Th2 cells to form an immunosuppressive microenvironment.\"},{\"question\":\"What evidence supports the prognostic value of B4GALNT1 in HCC?\",\"answer\":\"B4GALNT1 is verified as aberrantly upregulated in HCC tumor tissues and cells, and it is reported to act as an independent prognostic factor while improving prediction performance over traditional TNM staging.\"}]","Glycosyltransferase B4GALNT1 promotes immunosuppression in hepatocellular carcinoma via the HES4-SPP1-TAM/Th2 axis - Abstract | PDF",1790052461,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c23590b996acbe8b926a7f738a02635b.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0446de01c8670dbf45f8602f13ef6b45.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cc80eacc9c107aed86009670f83a6ae8.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5fba17b1e4d07a1155fb00b6b8ef32b7.webp",980,1301]